SCHEMBL1024600

SCHEMBL1024600

COCC(=O)NC(C)C(I)Nc1nccc(-c2oc(-c3ccc(F)cc3)nc2-c2cnc(N)c(OC)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.40
TNIK Q9UKE5 1/20 0.34
MAPK14 Q16539 8/20 0.33
GSK3B P49841 2/20 0.33
MAPK13 O15264 2/20 0.32
MAPK12 P53778 2/20 0.32
MAPK11 Q15759 2/20 0.32
MAPK8 P45983 2/20 0.32
PIK3CG P48736 2/20 0.32
CAMKK2 Q96RR4 2/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
CCNT1 O60563 1/20 0.32
CDK9 P50750 1/20 0.32
FYN P06241 1/20 0.32
NEK2 P51955 1/20 0.32
HDAC1 Q13547 1/20 0.31
SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1021943 0.88 MAPK14 (0.33) MAPK14MAPK13MAPK12MAPK11TP53
SCHEMBL68024 0.88 BRAF (0.47) BRAFTNIK
SCHEMBL68025 0.88 BRAF (0.47) BRAFTNIK
SCHEMBL67732 0.81 BRAF (0.53) BRAFTNIKMAPK14GSK3BPIK3CG
SCHEMBL69917 0.80 BRAF (0.47) BRAFHDAC1
SCHEMBL69916 0.80 BRAF (0.47) BRAFHDAC1
SCHEMBL68864 0.76 BRAF (0.36) BRAF
SCHEMBL68865 0.76 BRAF (0.36) BRAF
SCHEMBL66924 0.75 BRAF (0.49) BRAFHDAC1
SCHEMBL66806 0.74 BRAF (0.49) BRAFMAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2274300-A2 NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF Novartis AG (CH) 2011-01-19 EP claimed
WO-2009115572-A2 NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF NOVARTIS AG (CH) 2009-09-24 WO claimed
EP-2274300-A2 NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF Novartis AG (CH) 2011-01-19 EP disclosed
WO-2009115572-A2 NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF NOVARTIS AG (CH) 2009-09-24 WO disclosed